Navigation Links
Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
Date:5/16/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Reawakening a dormant gene could ease sic... (Vocus) December 4, 2008 -- Researchers ...tal.org ) and Dana-Farber Cancer Institute have id... form of hemoglobin normally made only before birt...sform sickle-cell disease and beta-thalassemia -- ...
(Date:12/4/2008)...4 Dr. Stephen Joffe, Craig Joffe, ... Schedule 13D with the U.S.,Securities and Exchan...disclosing ownership of 11.4% of LCA-Vision, Inc. ...xed-site laser vision correction centers in 33 sta...er and former Chairman and CEO of,LCAV. Craig Jo...
(Date:12/4/2008)...Is Mercury a Common Factor?" , , WASHINGTON...s announced last week call into question the safet...s old policy of routinely administering multiple v...sease in Autism Spectrum Disorder Patients, publi...he Cleveland Clinic, Johns Hopkins Kennedy Krieger...
(Date:12/4/2008)...derate-intensity activity or 75 minutes of vigorou...HealthDay News) -- An estimated 65 percent of peop...sical Activity Guidelines for Americans. And 49 pe...physical activity objectives, according to a feder...e 2008 guidelines, released in October by the U.S....
Breaking Medicine News(10 mins):Health News:Turning back the Clock in Inherited Anemias 2Health News:Turning back the Clock in Inherited Anemias 3Health News:Turning back the Clock in Inherited Anemias 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 3Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 5Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 6Health News:Researchers & Department of Defense Question Multiple Vaccine Administration 2Health News:Almost Two-Thirds of Americans Meet Exercise Guidelines 2Health News:Almost Two-Thirds of Americans Meet Exercise Guidelines 3
...ent study researchers say that a diet rich in calc...cheese, yogurt and fortified orange juice can actu... Syndrome (PMS) symptoms. Studies in the past have...e with PMS, however more recent studies suggest th...
...going to the dentists, but did you know that //whe...ou feel scared about dental appointments? A new st...mphasize that although women are 2.5 times as like...than men, men too are as likely to eel afraid, onl...
...to find out why the diabetes drug thiazolidinedion...niversity of Utah had found that the drug TZDs act...iferator-activated receptor gamma (PPAR). This is ...e kidney. The activation of the receptor serves to...
...se like SARS, Ebola, Marburg and Avian influenza c...into from a global perspective. In an article in t...ion Society of US have suggested that instead of t...int of individual countries that are being affecte...
Other Medicine News:
(Date:12/4/2008)...lif., Dec. 4 Thoratec Co...vice-based mechanical circulatory support,therapi...id today that a,pre-specified interim analysis of...DT) pivotal trial shows that patients implanted wi...comes versus those in the control group who,were ...
(Date:12/4/2008)...ember 4 Biopharmaceutical company ...fully completed treatment of the,last patient on ...a donor,lymphocyte cell based product, is under d...ease (GvHD) and allow early immune reconstitution ...n. Nineteen end stage blood cancer,patients were ...
(Date:12/4/2008).... 4 NovaRx Corporation announced t...to the position of President and Chief Operating O...an 25 years experience in drug discovery and a lon...eutical discovery and development. He also has ex...panies developing pioneering new technologies. Pr...
(Date:12/3/2008)...t-line data demonstrating potential in newly diagn...emia to be featured in two oral sessions at ASH ,...for chronically transfused patients by significant..., , - New long-term data from major indepen...imal post-surgery treatment strategy, Femara vs. t...
Breaking Medicine Technology:Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 2Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 3Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 4Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Bristol Myers Squibb Board Elects James M Cornelius Chairman of the Board 3224 1Bristol Myers Squibb Board Elects James M Cornelius Chairman of the Board 3224 2Breakthrough in pre eclampsia test 11643 1Breakthrough in pre eclampsia test 11643 2Nfocus Neuromedical Receives CE Mark for the CardioVasc 28TM 29 Stent Graft and Delivery System 11639 1Nfocus Neuromedical Receives CE Mark for the CardioVasc 28TM 29 Stent Graft and Delivery System 11639 2MBF Healthcare Acquisition Corp and Critical Homecare Solutions Holdings Inc to Present at the 2008 UBS Healthcare Services Conference 3221 1MBF Healthcare Acquisition Corp and Critical Homecare Solutions Holdings Inc to Present at the 2008 UBS Healthcare Services Conference 3221 2MBF Healthcare Acquisition Corp and Critical Homecare Solutions Holdings Inc to Present at the 2008 UBS Healthcare Services Conference 3221 3
...-Apr 26, 2007 - Northfield,Laboratories Inc. (Nasd...ch organization has informed the Company that the ...III trauma trial with,PolyHeme(R), the Company,s h...stitute, will not be complete until May., About No...c. is a leader in developing an,oxygen-carrying re...
...monstrates dramatic,benefits of adding Diovan to c...o superior outcomes for,Diovan patients , , , B...from the independent,Jikei Heart Study, published ... pressure lowering medication Diovan® to,conve...in,cardiovascular events and a 40% reduction in st...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human
... Aerosol Resistant Tips offer a safe alternative t...are designed for applications such as PCR(a), pipe...n addition, ART Tips are excellent for tissue cult...studies. ART Tips prevent aerosol contaminants and...
...ntGard Low Binding 0.5l - 10l Eppendorf Barrier Ti...ng technology that significantly reduces the amoun... filter tips are advertised as low retention, whic... pipet tip. However, AvantGard also focuses on low...
10 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 5 & 10 L pipettes. Ideal for pipetting into long, narrow tubes or deep well plates.
Medicine Products: